URAT1/GLUT9-IN-1 (compound 29) can inhibit both uric acid transporter 1 ( URAT1 ) ( IC 50 =2.01 μM) and glucose transporter 9 ( GLUT9 ) ( IC 50 =18.21 μM). URAT1/GLUT9-IN-1 exhibits favorable pharmacokinetic properties and oral bioavailability. URAT1/GLUT9-IN-1 can be uesd for gout and hyperuricemia research.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > GLUT | Products > Signaling Pathways > URAT1
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.